*contains promoted content
Hey Folks, Jeff Bishop here. Happy Hump Day!
Stocks pushed higher Tuesday as traders piled back into tech.
The Nasdaq hit another fresh intraday high as optimism around AI infrastructure spending keeps driving momentum back into the market.
At the same time, oil is still elevated, inflation pressures are back, and Wall Street see-saws between risk-on enthusiasm and macro uncertainty.
Right now I’m locked in on a “tactical trade” idea that began a “bottom bounce” on May 15 and has surged about 50% since then.
This is a small diagnostics company developing blood tests that could dramatically change how doctors detect cancer and sepsis.
Back in March, the company announced blinded validation results showing more than 95% detection rates for Stage I and Stage II cancers, while maintaining 95% specificity.
That’s worth paying attention to in a space worth tens of billions of dollars.
👉 Click Here To See Today’s Tactical Trade Idea 👈
But that’s only part of the story.
In April, the company also unveiled a breakthrough finger-prick sepsis test prototype that could potentially work similarly to a COVID rapid test.
It would be a simple bedside or at-home test designed to help identify one of the deadliest medical emergencies in the world.
And now Wall Street analysts are starting to take notice.
One firm recently raised its price target to $24, while another maintains a $20 target.
Meanwhile, the stock itself is still trading in the low single digits.
Management says it’s currently in discussions with more than a dozen of the world’s leading diagnostic and liquid biopsy companies.
Any licensing agreement there could be a major catalyst.
And unlike a lot of speculative biotech stories, this company is already generating revenue, which grew roughly 400% year over year in Q1.
Yesterday’s tactical trade idea surged as high as 27% intraday:
Now I’m watching this under-the-radar diagnostics play to see if it will keep up its breakneck momentum.
Click below to take a closer look:
👉 See Today’s Trade Idea 👈
To Your Success,
Jeff Bishop
DISCLOSURE: This entity is owned by Ragingbull. com, LLC (RB), disclosures located here: https://ragingbull.com/disclaimer. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.
*PAID PROMOTION/COMPENSATION DISCLOSURE: RB has received five hundred dollars (cash) for this one day program (via Sherwood Ventures) on May 27, 2026 for marketing efforts to increase public awareness of the company mentioned on this page HERE. RB may have been previously compensated for marketing efforts for this company as well. As RB has received compensation from the above-mentioned companies, all of these parties have financial interests in the securities referenced. RB and its affiliates may buy, sell, or hold positions in securities mentioned at any time without notice. Always consult a licensed financial professional before making investment decisions.
0 التعليقات:
إرسال تعليق